Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial

INTRODUCTION: Cisplatin (CDDP) is a key drug for various thoracic malignancies. To avoid renal toxicity of CDDP, mannitol is routinely used, but it sometimes causes phlebitis which damages patients’ quality of life. Furosemide is another widely used option for diuresis administered more quickly. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Eriko, Akamatsu, Hiroaki, Shimokawa, Toshio, Wada, Kiyoko, Yamamoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924869/
https://www.ncbi.nlm.nih.gov/pubmed/31831529
http://dx.doi.org/10.1136/bmjopen-2019-029057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924869/
https://www.ncbi.nlm.nih.gov/pubmed/31831529
http://dx.doi.org/10.1136/bmjopen-2019-029057

Ejemplares similares